Skip to main content
. 2013 Sep;38(5):325–332. doi: 10.1503/jpn.120160

Table 1.

Clinical and demographic characteristics of patients undergoing subcallosal cingulate deep brain stimulation for treatment-resistant depression

Characteristic Patient 1 Patient 2 Patient 3 Patient 4
Age, yr 49 56 46 50
Sex Female Female Male Female
Marital status Married Divorced Single Married
Family history of depression Yes Yes Yes Yes
Age at onset of MDD, yr 23 20 13 13
Current episode duration, mo 32 120 72 84
Lifetime no. of depressive episodes 2 5 6 1
Prior psychiatric hospital admission 1 3 2 2
Prior suicide attempt No No No No
Secondary Axis I diagnosis Agoraphobia with panic disorder Chronic fatigue syndrome Hypochondriasis Anorexia nervosa as a teenager
Prior psychotherapy Yes Yes Yes Yes
Previous medications Fluoxetine, citalopram, bupropion, lamotrigine, venlafaxine, plus augmentation with lithium, quetiapine Phenelzine, doxepin, fluoxetine, fluoxamine, sertraline, paroxetine, moclobemide, venlafaxine, amitriptyline, plus augmentation with lithium, trazodone, buspirone, tryptophan Amitriptyline, desipramine, imipramine, nortriptyline, phenelzine, fluoxetine tranylcypromine, fluoxamine, paroxetine, sertraline, venlafaxine, bupropion, moclobemide, lamotrigine, with thyroxine augmentation, St. John’s wort Bupropion, fluoxetine, phenelzine, moclobemide dualoxetine, escitalopram, mirtazepine, methylphenidate, plus augmentation with lithium, atypical antipsychotics, dexamphetamine
Medications (dosage) during SCC-DBS Citalopram (60 mg/d), clonazepam (0.5 mg qhs), lithium carbonate (600 mg/qhs), quetiapine (150 mg/qhs), multivitamins Dualoxetine (60 mg/d), zopiclone (22.5 mg/qhs), gabapentin (1200 mg/d), clonazepam (1.5 mg/d), synthyroid (0.15 mg/d) No antidepressants, vitamin D 4000 IU + calcium, sporadic testosterone im Dextroamphetamine (10 mg/d), risperidone (0.75 mg/qhs), mirtazepine (11.25 mg/qhs), aripiprazole (6 mg/qhs)
Prior ECT Transient positive response No response No response with severe memory deficits Positive response with severe memory deficits
Prior rTMS No prior treatment No prior treatment No response Responded but relapsed
Stages of treatment resistance* Stage IV Stage IV Stage IV Stage IV

ECT = electroconvulsive therapy; im = intramuscular; MDD = major depressive disorder; qhs = every evening or bedtime; rTMS = repetitive transcranial magnetic stimulation; SCC-DBS = deep brain stimulation of the subcallosal cingulate.

*

As per Thase and Rush.12